CFEIY logo

China Feihe Limited (CFEIY) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

CFEIY, $ (piyasa değeri 0) fiyatla Consumer Defensive işi olan China Feihe Limited'i temsil ediyor. Hisse senedi, 9 kantitatif KPI'ya dayalı olarak orta dereceli bir derecelendirme olan 50/100 puan alıyor.

Son analiz: 17 Mar 2026
50/100 AI Puanı

China Feihe Limited (CFEIY) Tüketici İşletmesi Genel Bakışı

CEOYoubin Leng
Çalışanlar9590
MerkezBeijing, CN
Halka Arz Yılı2020

China Feihe Limited is a leading infant milk formula producer in China, offering a range of nutritional products through a widespread distribution network encompassing both online platforms and traditional retail outlets, positioning it within the competitive packaged foods sector.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 17 Mar 2026

Yatırım Tezi

China Feihe Limited presents a compelling investment case based on its established market position in the Chinese infant milk formula industry and its extensive distribution network. With a P/E ratio of 11.61 and a profit margin of 13.6%, the company demonstrates solid profitability. A dividend yield of 7.25% offers an attractive return to investors. Growth catalysts include expanding product lines and increasing penetration in lower-tier cities. However, investors may want to evaluate potential risks such as regulatory changes in the infant formula industry and competition from both domestic and international players. The company's beta of 0.56 suggests lower volatility compared to the overall market.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Market capitalization of $4.52 billion, reflecting its significant presence in the Chinese infant milk formula market.
  • P/E ratio of 11.61, indicating a potentially undervalued stock relative to its earnings.
  • Profit margin of 13.6%, showcasing the company's ability to generate profits from its sales.
  • Gross margin of 63.4%, highlighting efficient cost management in production and sales.
  • Dividend yield of 7.25%, providing a substantial income stream for investors.

Rakipler & Benzerleri

Güçlü Yönler

  • Strong brand recognition in China.
  • Extensive distribution network.
  • Diverse product portfolio.
  • Established research and development capabilities.

Zayıflıklar

  • Heavy reliance on the Chinese market.
  • Vulnerability to regulatory changes in China.
  • Exposure to fluctuations in raw material costs.
  • Limited international presence.

Katalizörler

  • Ongoing: Expansion into new geographic markets within China, particularly lower-tier cities, is expected to drive revenue growth.
  • Ongoing: Product innovation and the introduction of premium infant milk formula products cater to evolving consumer preferences.
  • Ongoing: Continued growth in e-commerce sales through platforms like Tmall and JD.com.
  • Upcoming: Potential strategic partnerships or acquisitions to expand product portfolio and market reach.
  • Upcoming: Regulatory approvals for new product formulations or market expansions.

Riskler

  • Ongoing: Intense competition from both domestic and international brands in the Chinese infant milk formula market.
  • Ongoing: Regulatory changes in China's infant milk formula industry could impact production and sales.
  • Potential: Fluctuations in raw material costs, such as milk powder and other ingredients, could affect profitability.
  • Potential: Food safety concerns and negative publicity could damage brand reputation and consumer trust.
  • Potential: Economic slowdown in China could reduce consumer spending on infant milk formula.

Büyüme Fırsatları

  • Expansion into Lower-Tier Cities: China Feihe has the opportunity to further penetrate lower-tier cities in China, where demand for infant milk formula is growing rapidly. These markets often have less competition from international brands, allowing Feihe to gain market share. By leveraging its existing distribution network and tailoring products to local preferences, Feihe can tap into this significant growth potential. The market size for infant milk formula in lower-tier cities is estimated to be substantial, with ongoing growth expected through 2030.
  • Product Innovation and Premiumization: The company can drive growth by introducing new and innovative products, particularly in the premium segment. Chinese consumers are increasingly willing to pay more for high-quality and safe infant milk formula. Feihe can invest in research and development to create products with enhanced nutritional benefits and unique formulations. The premium infant milk formula market is projected to continue its expansion, offering significant revenue opportunities for Feihe.
  • E-commerce Channel Expansion: China Feihe can further expand its presence on e-commerce platforms such as Tmall, JD.com, and its own online channels. Online sales of infant milk formula are growing rapidly in China, driven by convenience and accessibility. By optimizing its online marketing strategies and improving its online customer service, Feihe can capture a larger share of the online market. This channel offers a direct-to-consumer approach, enhancing brand engagement and customer loyalty.
  • International Market Expansion: While primarily focused on the Chinese market, China Feihe has the potential to expand its presence in other international markets, particularly in Southeast Asia and other regions with significant Chinese diaspora populations. By adapting its products to local tastes and regulations, Feihe can tap into new sources of revenue and diversify its geographic risk. The global infant milk formula market is substantial, offering long-term growth opportunities for Feihe.
  • Strategic Partnerships and Acquisitions: China Feihe can pursue strategic partnerships and acquisitions to expand its product portfolio, enhance its distribution network, and gain access to new technologies. Collaborating with other companies in the food and beverage industry can provide synergies and accelerate growth. Acquisitions can also help Feihe to consolidate its market position and gain access to new markets or product categories. These strategic moves can strengthen Feihe's competitive advantage and drive long-term value creation.

Fırsatlar

  • Expansion into lower-tier cities in China.
  • Product innovation and premiumization.
  • E-commerce channel expansion.
  • International market expansion.

Tehditler

  • Intense competition from domestic and international brands.
  • Changing consumer preferences.
  • Food safety concerns.
  • Economic slowdown in China.

Rekabet Avantajları

  • Established brand reputation in the Chinese infant milk formula market.
  • Extensive distribution network across online and offline channels.
  • Strong research and development capabilities for product innovation.
  • Scale of operations providing cost advantages.

CFEIY Hakkında

Founded in 1962 and headquartered in Beijing, China Feihe Limited has grown to become a prominent player in the Chinese infant milk formula market. The company's core business revolves around the production and sale of infant milk formula products, catering primarily to the Mainland China market, with some presence in the United States. Over the years, China Feihe has expanded its product portfolio to include a variety of milk-based products, such as raw milk, adult milk powders, and liquid milk products. Additionally, the company offers health care products, soybean powder, goat milk powder, and nutritional supplements, including vitamins, minerals, and herbs. China Feihe distributes its products through an extensive network comprising distributors, e-commerce platforms like Tmall, JD.com, and Suning.com, its own website and mobile application (including WeChat), and approximately 2,000 offline customers with 110,000 retail points of sale as of December 31, 2021. This multi-channel approach allows the company to reach a broad customer base across different demographics and geographic locations within China.

Ne Yaparlar

  • Produces and sells infant milk formula products.
  • Offers raw milk and adult milk powders.
  • Manufactures liquid milk products.
  • Provides health care products.
  • Produces soybean powder and goat milk powder.
  • Retails vitamins, minerals, herbs, and other nutritional supplements.

İş Modeli

  • Manufactures and distributes infant milk formula and related products.
  • Sells products through distributors, e-commerce platforms, and its own website and mobile application.
  • Operates a distribution network of offline customers with numerous retail points of sale.

Sektör Bağlamı

China Feihe operates within the competitive packaged foods industry, specifically focusing on the infant milk formula market in China. This market is characterized by increasing demand due to rising disposable incomes and urbanization. However, it is also subject to stringent regulations and intense competition from both domestic and international brands. The industry is experiencing a trend towards premiumization, with consumers increasingly seeking high-quality and safe products. China Feihe's established brand and distribution network position it to capitalize on these trends.

Kilit Müşteriler

  • Infants and young children requiring milk formula.
  • Parents and caregivers seeking nutritional products for their children.
  • Adults consuming milk powders and health supplements.
AI Güveni: 80% Güncellendi: 17 Mar 2026

Finansallar

Grafik & Bilgi

China Feihe Limited (CFEIY) hisse senedi fiyatı: Price data unavailable

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

CFEIY için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

CFEIY için Wall Street fiyat hedefi analizi.

MoonshotScore

50/100

Bu puan ne anlama geliyor?

MoonshotScore, CFEIY'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: Youbin Leng

CEO

Youbin Leng is the CEO of China Feihe Limited, leading a workforce of 9,590 employees. His background includes extensive experience in the food and beverage industry, with a focus on dairy and nutritional products. He has held various leadership positions within China Feihe, contributing to the company's growth and expansion. His expertise spans across operations, marketing, and strategic planning.

Sicil: Under Youbin Leng's leadership, China Feihe has strengthened its market position in the Chinese infant milk formula industry. He has overseen the expansion of the company's product portfolio and the enhancement of its distribution network. Key milestones include increased market share and improved financial performance. He has also focused on strengthening the company's brand reputation and ensuring product quality and safety.

China Feihe Limited ADR Bilgileri Sponsorsuz

An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. CFEIY is traded as a Level 1 ADR, meaning it trades over-the-counter (OTC) without needing to meet the stricter requirements of listed exchanges. This allows U.S. investors to invest in China Feihe more easily.

  • Ana Piyasa Sembolü: Hong Kong Stock Exchange (CFEI), China
  • ADR Seviyesi: 1
  • ADR Oranı: 1:1
  • Ana Piyasa Sembolü: CFEI
Kur Riski: As an ADR, CFEIY is subject to currency risk. The value of the ADR is affected by fluctuations in the exchange rate between the U.S. dollar and the Chinese Yuan (CNY). If the CNY depreciates against the USD, the value of CFEIY in USD terms may decrease, impacting returns for U.S. investors.
Vergi Etkileri: Dividends paid on CFEIY ADRs are subject to foreign dividend withholding tax in China. The standard withholding tax rate is typically around 10%. However, tax treaties between the U.S. and China may reduce this rate. U.S. investors may be able to claim a foreign tax credit on their U.S. tax return for the amount of foreign tax withheld.
İşlem Saatleri: The Hong Kong Stock Exchange (where CFEI trades) operates on a different time zone than U.S. markets. Its trading hours are typically 9:30 AM to 12:00 PM and 1:00 PM to 4:00 PM Hong Kong time (GMT+8). This translates to overnight and early morning trading hours in the U.S., potentially impacting the ability of U.S. investors to react to news and events in real-time.

CFEIY OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited financial disclosure, and may not meet minimum listing requirements of major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the lack of regulatory oversight and potential for limited liquidity, requiring increased due diligence.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: Liquidity for CFEIY on the OTC market is likely to be limited. This means lower trading volumes and wider bid-ask spreads, potentially making it difficult to buy or sell shares quickly and at desired prices. Investors may experience price volatility and should be prepared for potential delays in executing trades.
OTC Risk Faktörleri:
  • Limited financial disclosure increases information asymmetry.
  • Lower trading volumes can lead to price volatility.
  • Wider bid-ask spreads increase transaction costs.
  • Potential for fraud or manipulation is higher on the OTC market.
  • Regulatory oversight is less stringent compared to listed exchanges.
Durum Tespiti Kontrol Listesi:
  • Verify the company's registration and legal status.
  • Obtain and review the latest financial statements, if available.
  • Assess the company's management team and their track record.
  • Research the company's industry and competitive landscape.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before investing.
  • Check for any regulatory actions or legal proceedings against the company.
Meşruiyet Sinyalleri:
  • Established operating history in the Chinese infant milk formula market.
  • Presence on major e-commerce platforms in China.
  • Significant market capitalization.
  • Dividend payments to shareholders.
  • Audited financial statements (if available).

CFEIY Hakkında Sıkça Sorulan Sorular

CFEIY için değerlendirilmesi gereken temel faktörler nelerdir?

China Feihe Limited (CFEIY) şu anda yapay zeka skoru 50/100, orta puanı gösteriyor. Temel güçlü yan: Strong brand recognition in China.. İzlenmesi gereken birincil risk: Ongoing: Intense competition from both domestic and international brands in the Chinese infant milk formula market.. Bu bir finansal tavsiye değildir.

CFEIY MoonshotScore'u nedir?

CFEIY şu anda MoonshotScore'da 50/100 (Derece C) alıyor, bu da orta derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

CFEIY verileri ne sıklıkla güncellenir?

CFEIY fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler CFEIY hakkında ne diyor?

CFEIY için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

CFEIY'a yatırım yapmanın riskleri nelerdir?

CFEIY için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Ongoing: Intense competition from both domestic and international brands in the Chinese infant milk formula market.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

CFEIY'ın P/E oranı nedir?

CFEIY için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için CFEIY'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

CFEIY aşırı değerli mi, yoksa düşük değerli mi?

China Feihe Limited (CFEIY)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

CFEIY'ın temettü verimi nedir?

China Feihe Limited (CFEIY) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Limited analyst coverage due to OTC listing.
  • Financial data may not be as readily available as for listed companies.
  • OTC stocks carry higher risks than exchange-listed stocks.
Veri Kaynakları

Popüler Hisseler